Singular Genomics Systems... (OMIC)
NASDAQ: OMIC
· Real-Time Price · USD
20.01
0.00 (0.00%)
At close: Feb 20, 2025, 3:55 PM
Singular Genomics Systems Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.58 | -0.25 | -0.37 | -0.36 | -0.31 | -0.59 | -0.98 | -1.83 | -1.94 | -2.85 | -5.09 | -10.55 | -11.39 | -12.81 | -18.29 |
PEG Ratio | 0.03 | 0.02 | -0.05 | -0.11 | 0.02 | -0.04 | -0.08 | 0.13 | 0.48 | -0.35 | -0.39 | -0.93 | 0.21 | -0.24 | -0.09 |
PS Ratio | 96.53 | 28.68 | 84.86 | 31.30 | 60.35 | 119.17 | 100.85 | 188.08 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.32 | 0.15 | 0.24 | 0.19 | 0.14 | 0.28 | 0.36 | 0.55 | 0.64 | 0.91 | 1.41 | 2.48 | 2.28 | 5.24 | -23.86 |
P/FCF Ratio | -1.98 | -1.17 | -1.58 | -1.75 | -1.65 | -2.96 | -4.81 | -6.62 | -7.77 | -9.76 | -21.56 | -47.75 | -63.71 | -114.26 | -180.56 |
P/OCF Ratio | -1.98 | -1.17 | -1.58 | -1.79 | -1.66 | -3.01 | -4.85 | -7.22 | -8.17 | -10.58 | -22.59 | -53.14 | -73.12 | -121.22 | -190.53 |
OCF/S Ratio | -48.74 | -24.47 | -53.63 | -17.49 | -36.39 | -39.6 | -20.78 | -26.04 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.41 | 0.52 | 0.47 | 0.42 | 0.39 | 0.27 | 0.24 | 0.23 | 0.21 | 0.20 | 0.05 | 0.03 | 0.03 | 0.03 | -2.06 |
Quick Ratio | 6.67 | 8.04 | 9.54 | 9.77 | 12.77 | 15.15 | 18.36 | 17.72 | 19.00 | 22.07 | 35.18 | 51.12 | 60.80 | 46.48 | 19.16 |
Current Ratio | 7.37 | 8.77 | 10.35 | 10.51 | 13.64 | 16.18 | 19.73 | 19.01 | 20.18 | 22.98 | 35.87 | 51.57 | 60.80 | 46.48 | 19.16 |
Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -63.19 | -79.73 | -94.54 | -88.09 | -86.1 | -102.23 | -97.98 | -92.72 | -117.03 | -145.17 | -155.07 | -102.46 | -74.62 | -59.84 | -54.59 |
Return on Equity | -0.14 | -0.15 | -0.16 | -0.13 | -0.11 | -0.12 | -0.09 | -0.08 | -0.08 | -0.08 | -0.07 | -0.06 | -0.05 | -0.1 | 0.33 |
Return on Assets | -0.09 | -0.1 | -0.1 | -0.09 | -0.08 | -0.09 | -0.07 | -0.06 | -0.07 | -0.06 | -0.06 | -0.06 | -0.05 | -0.1 | -0.15 |
Return on Invested Capital | -0.1 | -0.11 | -0.12 | -0.1 | -0.09 | -0.1 | -0.08 | -0.06 | -0.07 | -0.07 | -0.07 | -0.06 | -0.05 | -0.04 | -0.07 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | -0.74 | -0.24 | -4.84 | -0.42 | -0.14 | -0.18 | 0.06 | -0.03 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | -41.37 | -28.84 | -56.62 | -21.51 | -48.4 | -50.65 | -25.66 | -25.72 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | -41.37 | -28.84 | -56.62 | -21.51 | -48.4 | -50.65 | -27.38 | -27.58 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | -44.51 | -30.94 | -60.74 | -23.39 | -53.11 | -54.66 | -29.41 | -29.45 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -36.5 | -26.04 | -52.08 | -19.71 | -43.73 | -46.39 | -24.98 | -25.02 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |